I'm not ruling out that possibility and accept what you are saying is quite reasonable. You may have called this 100% correctly. I personally have tempered my own belief in that scenario as much for my own sanity as I view that as being a possibility but not a plan. It is very odd that they have said nothing regarding clinical updates since Sept and no explanation of the screening halt. However I personally think it prudent to plan for the trial to run its full course and not expect AA to happen. In that scenario and to further temper my excitement I expect the trial to take many more months ( maybe 12-15 months ) and this requires further clinical updates to steady the ship and further financing which if planned carefully will be based against a backdrop of positive clinical updates.
I want Jam now obviously but if I've learned one thing following NWBO it is that despite what I think might happen approval can only be achieved moving as fast as the slowest player in this team made up of Mgt, DMC, FDA, PEI, NHS, Capacity capability, Patients, Trial sites, investors, suppliers and painful to say but also HF's that short.